PosiFunda · Fundamentals

KYORIN Pharmaceutical Co., Ltd.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (5)

Compared with Healthcare companies in Japan.

P/E ratio

29.4

Investors pay 29.4 for every 1 of KYORIN Pharmaceutical Co., Ltd.'s yearly profit, higher than 81% of Healthcare companies in Japan.

P/B ratio

0.45

The share price is 0.45 times KYORIN Pharmaceutical Co., Ltd.'s book value per share, lower than 97% of Healthcare companies in Japan.

Market cap

¥63.8 B

The total market value of all of KYORIN Pharmaceutical Co., Ltd.'s shares at today's price (share price × number of shares), larger than 70% of Healthcare companies in Japan. PosiCap size class: Mini Cap.

Return on equity (ROE)

1.6%

KYORIN Pharmaceutical Co., Ltd. earned 1.6% on its shareholders' money over the last year, lower than 71% of Healthcare companies in Japan.

Dividend yield

4.15%

KYORIN Pharmaceutical Co., Ltd. pays 4.15% of its share price as dividends a year, higher than 88% of dividend-paying Healthcare companies in Japan.

Questions

What is KYORIN Pharmaceutical Co., Ltd.'s P/E ratio?

Investors pay 29.4 for every 1 of KYORIN Pharmaceutical Co., Ltd.'s yearly profit, higher than 81% of Healthcare companies in Japan.

What is KYORIN Pharmaceutical Co., Ltd.'s return on equity?

KYORIN Pharmaceutical Co., Ltd. earned 1.6% on its shareholders' money over the last year, lower than 71% of Healthcare companies in Japan.

Does KYORIN Pharmaceutical Co., Ltd. pay a dividend?

Yes. KYORIN Pharmaceutical Co., Ltd. pays 4.15% of its share price as dividends a year, higher than 88% of dividend-paying Healthcare companies in Japan.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.